Self-organizing molecular field analysis of 2,4-thiazolidinediones: A 3D-QSAR model for the development of human PTP1B inhibitors

被引:28
|
作者
Thareja, Suresh [1 ]
Aggarwal, Saurabh [1 ]
Bhardwaj, T. R. [1 ]
Kumar, Manoj [1 ]
机构
[1] Panjab Univ, Univ Inst Pharmaceut Sci, Chandigarh 160014, India
关键词
Diabetes; h-PTP1B; 3D-QSAR; SOMFA; Thiazolidinediones; INSULIN-RESISTANCE; PPAR-GAMMA; COMFA; COMSIA; OBESITY; THIAZOLIDINEDIONE; DERIVATIVES; LIGANDS;
D O I
10.1016/j.ejmech.2010.02.042
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Thiazolidinediones (TZDs) have been recently developed to treat diabetic patients that can reverse insulin resistance by activation of gamma isoform of peroxisome proliferator-activated receptor (PPAR-gamma). Self-Organizing Molecular Field Analysis (SOMFA) has been performed on TZD scaffold having h-PTP1B inhibitory activities for the development and optimization of lead. The master grids obtained from SOMFA models indicated significant electrostatic and shape potential contributions. These can be mapped back onto structural features relating to the trends in activities of the molecules. The robustness of generated SOMFA models was evidenced by various statistical measures. Overall, the present SOMFA study investigated the indispensable structural features of substituted TZDs which can be exploited for further structural modifications in order to optimize h-PTP1B inhibitors.
引用
收藏
页码:2537 / 2546
页数:10
相关论文
共 50 条
  • [21] 3D-QSAR studies on glycogen phosphorylase inhibitors by flexible comparative molecular field analysis
    ZHOU Peng1 & LI ZhiLiang1
    2 State Key Laboratory of Chemo/Biosensing and Chemometrics
    Science in China(Series B:Chemistry) , 2007, (04) : 568 - 573
  • [22] MOLECULAR DOCKING, 3D-QSAR AND DE NOVO DESIGN OF BENZIMIDAZOLES AND IMIDAZOLINES (S)-ISOTHIAZOLIDINONES DERIVATIVES AS PTP 1B INHIBITORS
    Granados R, Judith C.
    Arias P, Elsa R.
    Pacheco L, Dency J.
    Valdiris A, Veronica
    Vivas-Reyes, Ricardo
    VITAE-REVISTA DE LA FACULTAD DE QUIMICA FARMACEUTICA, 2010, 17 (03): : 317 - 327
  • [23] 3D-QSAR studies on glycogen phosphorylase inhibitors by flexible comparative molecular field analysis
    Zhou Peng
    Li ZhiLiang
    SCIENCE IN CHINA SERIES B-CHEMISTRY, 2007, 50 (04): : 568 - 573
  • [24] Formylchromone derivatives as novel and selective PTP-1B inhibitors: a drug design aspect using molecular docking-based self-organizing molecular field analysis
    Sant K. Verma
    Suresh Thareja
    Medicinal Chemistry Research, 2016, 25 : 1433 - 1467
  • [25] Formylchromone derivatives as novel and selective PTP-1B inhibitors: a drug design aspect using molecular docking-based self-organizing molecular field analysis
    Verma, Sant K.
    Thareja, Suresh
    MEDICINAL CHEMISTRY RESEARCH, 2016, 25 (07) : 1433 - 1467
  • [26] Self-organizing molecular field analysis on pregnane derivatives as human steroidal 5α-reductase inhibitors
    Aggarwal, Saurabh
    Thareja, Suresh
    Bhardwaj, Tilak Raj
    Kumar, Manoj
    STEROIDS, 2010, 75 (06) : 411 - 418
  • [27] A paradigm for development of novel PTP 1B inhibitors: Pharmacophore modelling, atom-based 3D-QSAR and docking studies
    Malla, Priyanka
    Kumar, Rajnish
    Mattewal, Samiya Kaur
    Mahapatra, Manoj Kumar
    Kumar, Manoj
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (02) : 927 - 938
  • [28] A paradigm for development of novel PTP 1B inhibitors: Pharmacophore modelling, atom-based 3D-QSAR and docking studies
    Priyanka Malla
    Rajnish Kumar
    Samiya Kaur Mattewal
    Manoj Kumar Mahapatra
    Manoj Kumar
    Medicinal Chemistry Research, 2014, 23 : 927 - 938
  • [29] Analysis of B-Raf inhibitors using 2D and 3D-QSAR, molecular docking and pharmacophore studies
    Aalizadeh, Reza
    Pourbasheer, Eslam
    Ganjali, Mohammad Reza
    MOLECULAR DIVERSITY, 2015, 19 (04) : 915 - 930
  • [30] 3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: Application of molecular field analysis
    Nunthanavanit, Patcharawee
    Anthony, Nahoum G.
    Johnston, Blair F.
    Mackay, Simon P.
    Ungwitayatorn, Jiraporn
    ARCHIV DER PHARMAZIE, 2008, 341 (06) : 357 - 364